The vaccine was approved for those 60 years of age and up to prevent RSV lower lung infection. The GSK vaccine is a recombinant subunit of prefusion RSV F glycoprotein antigen (RSVPreF3) with an ...

Fact Check: Q&A on the 2024-2025 COVID-19 Vaccines This marks the third year that vaccine manufacturers have updated their COVID-19 vaccine formulations to better match circulating variants.

Herein, the water-soluble polyphosphazene delivery vehicle assembles into nanoscale supramolecular constructs with the soluble extracellular portion of the Hendra virus attachment glycoprotein─a ...

"Subunit vaccines have been around for a long time, and they tend to be cheaper to produce, so that opens up more access to vaccines, especially in times of pandemic," Jaklenec says.

Current seasonal influenza vaccines are limited in that they need to be reformulated every year in order to account for the constant mutation of the virus. Hemagglutinin (HA) immunogens have been ...

Contract research firm ICON Plc said on Wednesday it is partnering with the U.S. government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.

Following President Biden’s Friday remarks that he plans to request funding for a new COVID vaccine amid rising cases, doctors sound off on whether another version is needed.

Description The various types of vaccine : Viral vector, mRNA, inactivation and Protein subunit in separation vial that represent in black and white icon concept.

Researchers described a novel protein subunit vaccine comprising the receptor-binding domain (RBD) of ancestral SARS-CoV-2 spike (S) protein, dimerized with an immunoglobulin (Ig)G1-fraction ...

The S2 subunit of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could protect against variants.